肺癌肾上腺转移彩超声像图分析

目的：探讨肺癌肾上腺转移的彩超声像图特征。方法：回顾性分析经粗针穿刺活检证实的14例肺癌肾上腺转移患者的临床及超声表现,包括肿瘤的位置、大小、形态、回声、边界、血流彩色多普勒显像（CDFI）表现等,并与穿刺病理结果比较。结果与结论：在14例患者中,肿瘤最大径3.0-15.3 cm。均为单侧肾上腺转移,腺癌转移9例,10例边界清晰、有包膜,10例形态不规则,13例为低回声,合并囊性变的仅1例,CDFI显示无血供或少血供的10例。肺癌肾上腺转移的声像图具有一定的特征性表现,超声易发现肾上腺肿瘤,可为临床诊断提供一定帮助。     

肾上腺少见肿瘤的CT、MRI评价

目的:探讨CT和MRI对肾上腺少见肿瘤的诊断及鉴别诊断价值。方法:对21例经手术和病理证实的肾上腺少见肿瘤的CT、MRI表现进行回顾性分析,包括囊肿8例、髓质脂肪瘤7例、神经节细胞瘤3例、神经纤维瘤、原发恶性淋巴瘤及恶性间皮瘤各1例。结果:14例(93%)肾上腺囊肿、髓质脂肪瘤有其特征性的CT、MRI表现而确诊,1例假性囊肿术前误诊为肿瘤;3例神经节细胞瘤中,1例为等密度肿块,轻度强化,1例大部囊变类似于假性囊肿,1例呈实性肿块,伴有囊变和钙化灶,明显不均匀强化;1例神经纤维瘤大部囊变;原发恶性淋巴瘤及恶性间皮瘤符合恶性肿瘤的影像学特征,但与常见的肾上腺恶性肿瘤鉴别困难。结论:CT、MRI对肾上腺少见肿瘤的诊断价值相似,后者有利于肿瘤的定位;大部分囊肿和髓质脂肪瘤可明确诊断,其它肾上腺少见肿瘤较难或不能与常见肿瘤鉴别,确诊仍需结合临床及组织学检查。     

The detection of adrenal tumors and hyperplasia in patients with primary aldosteronism: comparison of scintigraphy, CT, and MR imaging

We retrospectively reviewed the imaging studies in 17 proved cases of primary aldosteronism to determine the value of the procedures used to detect adrenal tumors or adrenal hyperplasia. The procedures included CT with 3-, 5-, and/or 10-mm-thick sections (17 patients), 131I-6 beta-iodomethyl-19-norcholesterol (NP-59) scintigraphy (16 patients), and MR imaging (six patients). Proof of the adrenal abnormality was established in cases of tumor (seven adenomas, one carcinoma) by surgery and in cases of adrenal hyperplasia by surgery (three cases); venous sampling (three cases); or combined clinical, biochemical, and imaging data (three cases). Both CT and scintigraphy detected six of the seven adenomas and the adrenal carcinoma (88%). Regarding hyperplasia, CT was correct in five of six and scintigraphy was correct in two of four cases proved by surgery or venous sampling. CT and NP-59 were concordant and suggested the diagnosis of hyperplasia in the remaining three cases without surgical or venous sampling proof. MR detected both cases of adenoma in which it was performed and showed evidence of hyperplasia in one of the four cases of hyperplasia in which it was performed. Although the number of patients in this series is too small to have much statistical power, these results suggest that CT and NP-59 scintigraphy are equivalent in the detection of adrenal abnormalities in patients with primary aldosteronism. The value of MR in the detection of small adrenal contour abnormalities was limited by slice thickness capabilities.     

增强CT诊断肝细胞癌肾上腺腺瘤与转移瘤的价值分析

目的 探讨增强CT对肝细胞癌肾上腺腺瘤与转移瘤的鉴别价值,以期为临床诊治提供参考依据.方法 回顾性分析2017年10月至2019年11月于我院接受治疗的41例肝细胞癌患者的临床资料,所有入选者均接受增强CT扫描,分析肝细胞癌肾上腺瘤与转移瘤的增强CT影像学特征及三期扫描CT值.结果 ①肾上腺腺瘤:瘤体为较小的圆形或卵圆...     

Imaging of nontraumatic hemorrhage of the adrenal gland.

Nontraumatic hemorrhage of the adrenal gland is uncommon. The causes of such hemorrhage can be classified into five categories: (a) stress, (b) hemorrhagic diathesis or coagulopathy, (c) neonatal stress, (d) underlying adrenal tumors, and (e) idiopathic disease. Computed tomography (CT), ultrasonography (US), and magnetic resonance (MR) imaging play an important role in diagnosis and management. CT is the modality of choice for evaluation of adrenal hemorrhage in a patient with a history of stress or a hemorrhagic diathesis or coagulopathy (anticoagulant therapy). CT may yield the first clue to the diagnosis of adrenal insufficiency secondary to bilateral massive adrenal hemorrhage; such insufficiency is rare but life threatening. US is the modality of choice for evaluation of neonatal hematoma, and MR imaging is helpful for further characterization. MR imaging is also useful in the diagnosis of coexistent renal vein thrombosis. When an adrenal abscess is suspected, percutaneous aspiration and drainage under imaging guidance should be performed. Hemorrhage into an adrenal cyst or tumor can cause acute onset of symptoms and signs in a patient without discernible risk factors for adrenal hemorrhage. A hemorrhagic adrenal tumor should be suspected when CT or MR imaging reveals a hemorrhagic adrenal mass of heterogeneous attenuation or signal intensity that demonstrates enhancement.     

肾上腺髓性脂肪瘤的影像诊断

目的 探讨肾上腺髓性脂肪瘤的影像学特征及鉴别诊断。方法 11例经手术及病理证实的肾上腺髓性脂肪瘤患者术前均经B超与CT诊断，其中9例又经MRI检查。对全部病例获自上述3种影像手段的所有资料进行了回顾性分析。结果 研究证实，肾上腺髓性脂肪瘤具有特征性影像表现。11例患者术前定位、定性诊断准确率，B超为63．6％(n=7)，CT与MRI均为100％(n=11)。结论 CT是确诊本病的首选方法，而各种影像特征的综合分析对本病确诊和鉴别诊断起关键作用。     

Diagnosis and management of adrenal incidentaloma

The growing demand for imaging tests and the progressive aging of the population have led to a progressive increase in the detection of indeterminate adrenal lesions. Once an adrenal incidentaloma is detected, clinical and hormone tests together with a battery of imaging techniques (CT, MRI, PET/CT…) make it possible to determine the cause in most cases. In this article, we discuss the advantages and limitations of each technique. We show the imaging characteristics of the most common adrenal lesions and propose a diagnostic algorithm to enable their diagnosis.     

Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions.

OBJECTIVE: The aim of this study was to differentiate benign from malignant adrenal tumors using positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in patients with unilateral adrenal masses originally detected by CT or MR imaging. CONCLUSION: PET imaging with FDG can metabolically characterize adrenal masses. Abnormally increased FDG uptake in adrenal malignancies allows one to differentiate these abnormalities from benign lesions. Whole-body PET can also reveal extraadrenal tumor sites in patients with malignant tumors, using a single imaging technique for accurate disease staging.     

MR imaging in the management of thoracic malignancies

CT remains the modality of choice for evaluating patients with a thoracic malignancy. In specific cases MR imaging can provide useful information that cannot be obtained with CT, and thus is useful as a problem solving tool. Advantages of MR imaging include superb demonstration of vessels and vessel/mass relationships, direct multiplanar imaging capability, and the potential for tissue characterization. MR imaging is useful in staging the patient with lung cancer when vascular or mediastinal invasion is in question. Its specific applications in surgical planning include the question of chest wall invasion, brachial plexus involvement, and transgression of the diaphragm, pericardium, or lung apex. Multiplanar imaging is useful in radiation therapy planning, displaying lesion extent in a coronal or sagittal format rather than on multiple axial images. Multiplanar capability also resolves problem areas for CT such as the aortopulmonic window, subcarinal region, and lesions at the cervicothoracic or thoracoabdominal junction. Structures such as the trachea and superior vena cava can be evaluated in their plane of anatomic orientation. Routine spin-echo and fast (GRASS) imaging of mediastinal vessels is useful in the evaluation of venous thrombosis as a result of catheters or tumors. The diagnosis and follow-up are obtained without the use of intravenous contrast material or radiation. When CT cannot evaluate vessels adequately because of surgical clip artifacts or postoperative distortion of anatomy, MR imaging is useful in the determination of vessel patency as well as identification of tumor recurrence. Cardiac masses are very well demonstrated by MR imaging. A unique feature of MR imaging is its potential for tissue characterization and ability to assess disease activity. Lymphoma evaluation is an active area of research. MR imaging can evaluate the radiated patient for tumor response and recurrence. Fibrous tissue remains of low signal intensity on T2-weighted images, whereas tumor has increased signal intensity. MR imaging may detect tumor recurrence before an increase in the size of a residual lymphoma mass and before clinical recurrence is evident. The area of increased signal can also serve as a guide to the appropriate site for biopsy to confirm recurrence. In addition, MR imaging can help characterize some adrenal and liver masses, potentially helping to avoid more invasive diagnostic procedures. At the current time MR spectroscopy does not have a clinical role in thoracic malignancies, but it may be a powerful tool in the future for diagnosis and management.     

Adrenal magnetic resonance imaging in Addison's disease

Magnetic resonance imaging of the adrenal glands was performed in 9 patients with Addison's disease to evaluate the role of magnetic resonance (MR) in this entity. All patients had bilateral adrenal masses demonstrated by computed tomography (CT); etiologies included adrenal hemorrhage (2 patients), granulomatous disease (1 patient), adrenal lymphoma (3 patients), and adrenal metastases (3 patients). Spin-echo axial images were obtained at repetition times (TR) 0.5, 2.0 s and TE 28, 56 ms, using a Diasonics superconducting magnet operating at 0.35 T. In the patients with lymphoma, metastases, and granulomatous disease, the adrenal masses appeared hypointense or isointense with liver on the T1-weighted images (TR 0.5 s, TE 28 ms). In cases of adrenal hemorrhage, areas of hyperintensity were seen on TR 0.5, TE 56 ms sequences, due to shortening of T1 values. In both groups of patients the masses were hyperintense on T2 weighted sequences. Mean calculated T1 of the hemorrhagic glands was 449 ms, compared with a mean of 782 ms for metastases and lymphoma. While MR is not capable of distinguishing between acute inflammatory and metastatic diseases of the adrenal glands, it may be equally efficacious as CT in suggesting the diagnosis of adrenal hemorrhage in patients with Addison's disease.     

MR imaging of the adrenals: correlation with computed tomography

The purpose of this study was to evaluate the role of magnetic resonance (MR) imaging in adrenal disease based on correlative imaging with CT. Fifty lesions in 36 patients with a variety of adrenal diseases were evaluated, at 0.5 T using spin echo (SE) multislice short repetition time (TR) and SE multislice multiecho long TR sequences. It is concluded that MR is capable of identifying most adrenal abnormalities previously detected by CT. The results suggest that MR has a greater specificity for mass lesions and might be useful to differentiate nonfunctioning adenomas from functioning adenomas, metastasis, pheochromocytomas, cysts, and intraadrenal hemorrhage. Magnetic resonance imaging also has the potential to detect aldosteronomas by increased signal intensity in addition to contour distortion using long TR/echo time sequences. The ability to perform multiplanar imaging and the presence of superior contrast as compared with CT are useful for the assessment of origin and extension of large lesions and the detection of pheochromocytomas in complex cases. Considering MR's limitations, we believe that at present its major role in evaluation of adrenal disease should be complementary to CT.     

Magnetic resonance imaging of the adrenal gland]

Adrenal imaging was performed using magnetic resonance (MR) was in 100 patients who had no clinical or biochemical evidence of adrenal abnormality and in 19 patients with 24 adrenal lesions (adenoma in 5, hyperplasia in 2, metastasis in 5, (lung cancer in 1, hepatoma in 4) adrenal cancer in 1, pheochromocytoma in 3, neuroblastoma in 3). Normal adrenal glands showed intermediate intensity between muscle and liver, and were detected in over 90% of cases on T1-weighted images (T1-weighted SE, inversion recovery). Adenomas and hyperplasias had the same intensity as normal glands. Medullary masses showed extreme hyperintensity on T2-weighted images and could be differentiated from cortical masses. Neuroblastomas were detected as hyperintense tumors with intratumoral hemorrhage and necrosis on T2-weighted MR images. Metastatic adrenal tumors from lung cancer were hyperintense on T2-weighted images, while metastasis from hepatoma showed low intensity on the same pulse sequence. In diagnosing adrenal metastasis, we must compare and contrast the tumor intensity and structure with those of the primary lesions. MR is considered a useful modality in characterizing adrenal tissue.     

Imaging of adrenal masses.

Adrenal pathology may be discussed based on hormonal functionality of the adrenals, appearances on imaging modality, or pathological determination. There are three main categories of adrenal function. Hyperfunctional states include Conn's or Cushing's syndrome. Lesions with normal function may be detected incidentally. Hypofunctional states may occur from idiopathic Addison's disease or some bilateral adrenal pathology. The most common modalities for characterization of adrenal pathology are non-enhanced CT, often followed by contrast CT or chemical shift MRI. The common appearance on non-enhanced CT is a well-defined homogeneous lesion with low-density due to the microscopic fat present and adrenal adenomas. When density criteria are not met, many of these may be characterized as adenomas by washed out of contrast or signal decrease using in phase and out-of-phase MRI sequences. Other non-invasive modalities may incidentally discover adrenal lesions, but are not typically used in the work-up. NP-59 is an uncommonly used nuclear medicine technique which is very specific for adenoma when correlated with pathology on other imaging studies. In the rare cases where non-invasive imaging is non-specific, fine needle aspiration or core biopsies may be necessary. However, biopsies have associated risks including infection and hemorrhage. The imaging appearance of an adrenal lesion is often specific such that further imaging is not necessary. These lesions include adrenal adenoma, pheochromocytoma, myelolipoma, adrenal cyst, and some large adrenocortical carcinomas. However, the findings in lesions such as metastasis, smaller primary adrenal carcinomas, lymphoma, granulomatous disease, and many adenomas are not as specific. In the proper clinical situation, follow-up imaging may be necessary, or biopsy may be warranted.     

CT and MRI of adrenal lesions

Adrenal lesions can be divided into those that result in clinical syndromes due to excess hormone elaboration and those that are nonhyperfunctioning. Computed tomography (CT) is usually adequate to assess the adrenal glands in patients with hyperfunctional disease. Occasionally supplementation with radionuclide studies, magnetic resonance (MR) or venous sampling, is required. Lesions which are not hyperfunctioning are often detected as an incidental mass. The CT and MR characteristics often allow a confident diagnosis based on their imaging characteristics. The adrenal glands are a common site of metastatic disease which can be detected by CT and further characterized by MR or biopsy if the stage of disease is uncertain.     

肾上腺畸胎瘤的影像诊断

目的　探讨肾上腺畸胎瘤影像表现 ,提高对本病的认识。方法　报告 4例经手术病理证实的肾上腺畸胎瘤的影像所见 ,IVP检查 2例 ,B超 3例、CT检查 4例 ,MRI和肾动脉造影各 1例。结果　 4例均位于右侧肾上腺 ,IVP示肾上腺区钙化灶 ,CT表现为右肾上腺显示不清。肿瘤分别表现为以水样密度、脂肪密度或实性密度为主的混合密度块 ,增强扫描肿瘤实质部分、包膜及分隔有强化 ,MRIT1、T2 WI均显示肿瘤为不均质性高信号。B超显示肾上腺区不均质强光团和多种成分回声。结论　CT、MRI对肾上腺畸胎瘤诊断和鉴别诊断优于IVP和B超。     

多层螺旋CT对肾上腺转移瘤的诊断

目的：探讨肾上腺转移瘤的CT特征及CT在肾上腺转移瘤诊断中的应用价值。方法：对52例病人作CT扫描,其中47例作增强扫描。结果：单侧肾上腺肿块38例（73%）,双侧22例（27%）。肿块直径范围1.5 cm~12 cm,分别呈圆形、卵圆形和分叶状不规则形。密度为实性、囊性或囊实性,增强后实性肿块及囊壁有强化。结论：CT是发现肾上腺肿瘤可靠、有效的检查方法。肾上腺转移瘤的诊断是综合性的,包括原发癌史、恶性征等。肾上腺肿块的恶性征为肿块直径〉5.0 cm,常呈分叶或不规则外形,密度不均。     

The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.

The aim of this study was to evaluate the role of radionuclide imaging in the characterization of nonhypersecreting adrenal masses. METHODS: A total of 54 patients (19 men, 35 women; mean age, 50 +/- 16 y) with nonhypersecreting unilateral adrenal tumors that had been originally detected on CT or MRI underwent adrenal scintigraphy using different radiotracers. None of the patients showed specific symptoms of adrenal hypersecretion. Screening tests for excess cortical and medullary products showed normal adrenal hormone levels. Radionuclide studies (n = 73) included (131)I-norcholesterol (n = 24), (131)I-metaiodobenzylguanidine (MIBG) (n = 23), and (18)F-FDG PET (n = 26) scans. RESULTS: Histology after surgery (n = 31) or adrenal biopsy (n = 23) was obtained. Adrenal lesions were represented by 19 adenomas, 4 cysts, 1 myelolipoma, 1 neurinoma, 2 ganglioneuromas, 5 pheochromocytomas, 4 pseudotumors, 6 carcinomas, 2 sarcomas, and 10 metastases (size range, 1.5- to 5-cm diameter; mean, 4.9 +/- 3.1 cm). For norcholesterol imaging, diagnostic sensitivity, specificity, and accuracy were 100%, 71%, and 92%, respectively; the positive predictive value (PPV) of the norcholesterol scan to characterize an adrenal mass as an adenoma was 89%, whereas the corresponding negative predictive value (NPV) to rule out this type of tumor was 100%. For MIBG imaging, diagnostic sensitivity, specificity, and accuracy were 100%, 94%, and 96%, respectively; the PPV of the MIBG scan to characterize an adrenal mass as a medullary chromaffin tissue tumor was 83%, whereas the corresponding NPV to rule out this type of tumor was 100%. For FDG PET, diagnostic sensitivity, specificity, and accuracy were 100%, 100%, and 100%, respectively; the PPV of FDG PET to characterize an adrenal mass as a malignant tumor was 100%, whereas the corresponding NPV to rule it out was 100%. Furthermore, in 7 patients with malignant adrenal tumors, FDG whole-body scanning revealed extra-adrenal tumor sites (n = 29), allowing an accurate diagnosis of the disease's stage using a single-imaging technique. CONCLUSION: In patients with nonhypersecreting adrenal masses, radionuclide adrenal imaging, using specific radiopharmaceuticals such as norcholesterol, MIBG, and FDG, may provide significant functional information for tissue characterization. Norcholesterol and MIBG scans are able to detect benign tumors such as adenoma and pheochromocytoma, respectively. Conversely, FDG PET allows for recognition of malignant adrenal lesions. Therefore, adrenal scintigraphy is recommended for tumor diagnosis and, hence, for appropriate treatment planning, particularly when CT or MRI findings are inconclusive for lesion characterization.     

Adrenal magnetic resonance imaging in addison’s disease

Magnetic resonance imaging of the adrenal glands was performed in 9 patients with Addison’s disease to evaluate the role of magnetic resonance (MR) in this entity. All patients had bilateral adrenal masses demonstrated by computed tomography (CT); etiologies included adrenal hemorrhage (2 patients), granulomatous disease (1 patient), adrenal lymphoma (3 patients), and adrenal metastases (3 patients). Spin-echo axial images were obtained at repetition times (TR) 0.5, 2.0 s and TE 28, 56 ms, using a Diasonics superconducting magnet operating at 0.35 T. In the patients with lymphoma, metastases, and granulomatous disease, the adrenal masses appeared hypointense or isointense with liver on the T₁-weighted images (TR 0.5 s, TE 28 ms). In cases of adrenal hemorrhage, areas of hyperintensity were seen on TR 0.5, TE 56 ms sequences, due to shortening of T₁ values. In both groups of patients the masses were hyperintense on T₂ weighted sequences. Mean calculated T₁ of the hemorrhagic glands was 449 ms, compared with a mean of 782 ms for mestastases and lymphoma. While MR is not capable of distinguishing between acute inflammatory and metastatic disases of the adrenal glands, it may be equally efficacious as CT in suggesting the diagnosis of adrenal hemorrhage in patients with Addison’s disease.     

Ultrasound in the detection of adrenal tumours

An analysis was made of the ultrasound (US) findings in 110 patients with proven or ultrasonographically suspected adrenal tumours. A total of 212 glands were imaged, 117 of which contained a tumour. The diagnosis was confirmed histologically in 50 cases and by imaging and follow-up in 162 cases. Normal glands were visualized ultrasonically in 27 out of 40 glands on the right and 5 out of 55 on the left. US detected 55 out of 59 primary adrenal tumours and 49 out of 58 secondary tumours, showing a sensitivity of 89%. In 13 tumours ultrasonography gave a false negative result, and in 13 cases a false positive one. Benign or primary malignant tumours and metastases could not be differentiated on the basis of echo-structure, but a large heterogeneous tumour in a patient with no known extra-adrenal malignancy is probably a primary malignant adrenal tumour.     

Clinical use of urinary tract magnetic resonance imaging

MR imaging should not be used to evaluate the majority of the lesions described herein but should be reserved for specific clinical situations. The detection and differential diagnosis of adrenal masses is a legitimate application of this technique. The staging of renal tumors in patients in whom CT fails to do so may be accomplished by MR imaging. Establishment of patency of the renal veins and of surgical shunts involving these veins may be performed by MR imaging if Doppler ultrasonography proves unsatisfactory. MR imaging may differentiate between stable retroperitoneal fibrosis and malignant disease in patients in whom this differential is a problem. Hematomas may be distinguished from nonhemorrhagic fluid collections anywhere in the abdomen or pelvis. In selected patients, the local extent of certain bladder tumors may be evaluated by MR imaging when CT and biopsy fail to do so. In testicular disease, MR imaging may aid in the differential diagnosis of abnormalities that are not sufficiently characterized by ultrasonography, and MR imaging may detect undescended testes in some patients in whom ultrasonography fails to do so. In the future, wider application of fast scanning with bolus administration of soluble paramagnetic contrast agents may refine the differential diagnosis of adrenal masses and aid in the detection of renal masses. MR angiographic techniques ultimately may constitute a screening procedure for renal arteriostenosis. A subset of patients with prostate carcinoma may prove to benefit from local staging of the disease by MR imaging.